LA Cystic Fibrosis Teen Recieves Double Lung Transplant for Holidays
Advancements in transplant surgery has given cystic fibrosis patients new hope for successful lung transplants.

LA Cystic Fibrosis Teen Recieves Double Lung Transplant for Holidays

Shelby Klug, a 17-year-old from LA, was diagnosed with cystic fibrosis (CF) at age 2. Cystic fibrosis is a genetic disorder that causes damage to the lungs and digestive system.…

Continue Reading LA Cystic Fibrosis Teen Recieves Double Lung Transplant for Holidays
This Drug is the Best and Worst News for Cystic Fibrosis
This CF drug is good news for health... and also awful news financially.

This Drug is the Best and Worst News for Cystic Fibrosis

Not long ago, Vertex Pharmaceuticals scored a big one for their investors—the European Commission has approved the use of ORKAMBI® (lumacaftor/ivacaftor), for the treatment of cystic fibrosis. This breakthrough treatment will be used…

Continue Reading This Drug is the Best and Worst News for Cystic Fibrosis

FH Patients Win Big In Innovative New “Pay to Perform” Deal

So here’s a nice antidote to all those stories about greedy pharma execs soaking patients for ultra-expensive treatments. There’s a new approach to contrpay-acting between insurance companies and pharmaceutical companies…

Continue Reading FH Patients Win Big In Innovative New “Pay to Perform” Deal
UVA Ph.D and One of the Longest-Living Cystic Fibrosis Survivors Inspires
Source: Patrick Neil (https://commons.wikimedia.org/wiki/User:Patrickneil)

UVA Ph.D and One of the Longest-Living Cystic Fibrosis Survivors Inspires

This month, I came across the most refreshing article written by Caroline Newman and featured in UVA Today's Art & Culture section about one of the longest living cystic fibrosis survivors.…

Continue Reading UVA Ph.D and One of the Longest-Living Cystic Fibrosis Survivors Inspires